Task: Answer the multiple choice question.
Question: Which drug exhibits a 15.353\% human ether-à-go-go related gene (hERG) inhibition at 1uM?
Constraint: You must select none, one or more options from a, b, c, or d without using any other words.
Options:
a.) Cc1cccc(CN2CCC(C(N)=O)CC2)c1
b.) CCN(CC(=O)Nc1cccc(S(N)(=O)=O)c1)Cc1nc2ccccc2c(=O)[nH]1
c.) CCOc1ccc(-n2c(-c3ccccc3)c[nH]c2=S)cc1
d.) CC(C)c1ccc(NC(=O)CSc2nc3ccsc3c(=O)n2CCC(=O)O)cc1
Answer: d. CC(C)c1ccc(NC(=O)CSc2nc3ccsc3c(=O)n2CCC(=O)O)cc1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_1uM#}{herg_central_at_1uM__units} {herg_central_at_1uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_1uM%}
Answer: {%multiple_choice_result}. {SMILES#}
CC(C)c1ccc(NC(=O)CSc2nc3ccsc3c(=O)n2CCC(=O)O)cc1
CC(C)c1ccc(NC(=O)CSc2nc3ccsc3c(=O)n2CCC(=O)O)cc1
3-[4-oxo-2-[2-oxo-2-(4-propan-2-ylanilino)ethyl]sulfanylthieno[3,2-d]pyrimidin-3-yl]propanoic acid